BBR ALO Fund: Dec 9 Vote and Dec 16 Tender Offer, 2026

What the fund is

BBR ALO Fund, LLC was organized in Delaware on January 10, 2020 and began operating on May 1, 2020. Its annual report for the year ended March 31, 2026 says its objective is long-term capital appreciation and that it deploys its assets among “long-biased equity investment managers” and the unregistered funds and accounts they run. The adviser is BBR Partners, LLC, at 55 East 52nd Street in New York; four subadvisers manage slices of the portfolio: Maren Capital, AllianceBernstein, Quantum Capital Management and Summit Street Capital Management. AllianceBernstein started on June 30, 2025, replacing Polen Capital after a shareholder vote on June 27, 2025.

It is not an interval fund and has no market price. The cover letter of the October offer says: “Shares can be redeemed by means of a tender offer only during one of the Fund's announced tender offers.” For how that differs from a fund that must repurchase every quarter, see what an interval fund is and our census of tender-offer funds.

At March 31, 2026 the fund held net assets of $1,839,136,300. Common stocks were 81.6% of net assets (industrials 19.3%, financials 15.3%, technology 14.3%), cash equivalents 7.0% and one Investment Fund, HWC Long Onshore Fund, LP, $242,756,486 or 13.2% of net assets. The largest common stock, HEICO Corp., Class A, was $51,780,808, 2.8% of net assets (our arithmetic). All the common stocks are Level 1 (priced from market quotes); the Investment Fund is valued at the net asset value it reports.

The calendar: seven days between the vote and the tender deadline

The first proxy of October 9 had the share count and the statement about 5% holders in brackets. The October 23 version fills them in, adds the amount paid to AllianceBernstein and adds one sentence: the current AllianceBernstein agreement “has been submitted to Fund shareholders for approval only once”, at the June 27, 2025 meeting. It still carries a bracketed mailing date of late October, so the definitive proxy is the document to read before voting.

Proposal 1: from diversified to non-diversified

The proxy explains that a fund that operated within diversified limits for three consecutive years is treated as diversified, and that a diversified fund cannot become non-diversified without a shareholder vote. It says the fund “became a diversified fund in June 2026”. A diversified fund must keep at least 75% of its total assets in cash, government securities, other investment companies and other securities limited, per issuer, to 5% of the fund's assets and 10% of the issuer's voting securities. A non-diversified fund is not held to that test.

What the proxy says would change: the fund “will not immediately reposition”, its goal and strategies “remain unchanged”, and the adviser reserves the freedom to run it either way. What it says is the risk: a fund tied to fewer issuers “is likely to become more volatile than the performance of more diversified funds”. If the adviser does not use the freedom within three years of the vote, the proxy says the fund would have to ask shareholders again. The fund also says it will keep meeting the diversification tests of Subchapter M of the Internal Revenue Code, which protect its tax treatment.

How concentrated is the fund today? At March 31, 2026 its single largest position was the private HWC Long Onshore Fund, LP at $242,756,486, which is 13.2% of net assets and 12.9% of total assets of $1,888,348,160 (our arithmetic). The largest stock was 2.8%. A position that size sits outside the 5% limit the proxy describes, so it can only fit in the part of the portfolio the test does not cover (our reading of the proxy's description, not a legal opinion).

The July 7, 2026 offer still said non-diversified three weeks after the June date the proxy gives, and the October 2 offer says diversified (our reading: the wording of the tender documents lagged the change). One more sentence is worth asking BBR about. Item 8 of the October 2 Offer to Purchase says the fund has no plans or proposals for “any changes in its fundamental investment policy for which a vote would be required by Section 13 of the 1940 Act”. The proxy says the board approved Proposal 1 on September 24, 2026, and the preliminary proxy followed on October 9, seven days after the Offer. The proxy calls diversification status a fundamental policy. We found no amendment to the Offer; the two documents do not refer to each other.

Proposal 2: AllianceBernstein, and what the Equitable-Corebridge merger does to the contract

AllianceBernstein L.P. runs its International Strategic Core strategy, quality large-cap stocks listed outside the United States, for part of the fund; the proxy names two portfolio managers who will continue. The fee is 0.30% of the allocated assets, paid monthly, the same as today. In the year to March 31, 2026 the fund paid AllianceBernstein $1,014,321, which is 12.3% of the $8,215,178 of subadvisory fees accrued that year (our arithmetic). In the 2025 proxy that brought AllianceBernstein in, the rate was 0.30% against 0.35% for Polen, and the weighted average subadvisory fee was expected to fall from 0.55% to 0.54%.

The vote is needed for a legal reason, not a performance one. Under the 1940 Act a subadvisory contract ends automatically on an “assignment”, which includes an indirect transfer of control of the adviser. The proxy says the Equitable-Corebridge merger “may constitute” one. The new agreement is identical except for the date and its initial term, which would run to March 31, 2028, and it takes effect on the later of shareholder approval and the merger closing.

The board's review is not all praise. On September 24, 2026 the board noted that the AllianceBernstein portion performed below comparable AllianceBernstein funds and accounts over one year, and below its index over one year and since inception. It weighed that against market conditions and the short time AllianceBernstein has run the money.

We checked the merger facts the proxy relies on against the companies' own filings:

So the premise holds: the merger is signed, the stockholders have voted yes, and closing is not done. If it slipped past December, the new agreement would not take effect until it closed. If Proposal 2 failed and the merger closed, the proxy says only that the board “would consider what additional actions, if any, would be appropriate”; it does not say who would manage that slice. Separately, AB announced on September 25, 2026 that its chief executive will retire effective March 31, 2027 (Equitable 8-K, 0001333986-26-000048); the proxy says the merger is not expected to change AllianceBernstein's day-to-day operations or personnel.

How many votes it takes

The proxy uses the 1940 Act majority: the vote of 67% or more of the shares present, if more than 50% of the shares are present, or more than 50% of the shares outstanding, whichever is less. Quorum is one-third of the shares eligible to vote. Abstentions count as present but not as votes for, so they act as votes against, and the proxy expects no broker non-votes because no shares are held by brokers or nominees. No person is known to own more than 5%, and the directors and officers together own less than 1%.

Read plainly, the meeting can open on one-third of the shares but each proposal can only pass if more than half are voted; below that the test cannot be met (our reading of the statutory definition the proxy quotes). No holder is known to own more than 5%, so turnout, not a single block, decides the result (our reading). Compare a fund where one holder decides: the City National Rochdale Strategic Credit Fund vote is controlled by a single adviser's accounts. For funds that struggled to reach quorum at all, see non-traded REIT quorum failures.

A shareholder can change a vote until it is cast: by delivering a later-dated proxy, a written notice of revocation to Broadridge, or by voting by ballot at the meeting. The fund pays the costs of the meeting; the Broadridge fee estimate is $6,678 plus disbursements.

The tender offer, term by term

The Offer's own warning on price: the NAV “likely will change” between August 31, 2026 and December 31, 2026. The per-share NAVs stated in the last three offers were $14.36 (February 28, 2026), $14.40 (May 31, 2026) and $15.21 (August 31, 2026). The audited figure at March 31, 2026 was $13.57, after the year's distributions. From $13.57 to $15.21 is a rise of 12.1% in five months (our arithmetic).

Nine offers in one table

Each completed offer was accepted in full and paid, and the fund raised its cap from $60 million to $75 million with the September 2025 offer. The seven completed offers add up to $285,503,482 on $480,000,000 of caps. The June 2026 acceptance was 3.3% of the $1,960,795,613 fund NAV shown in that offer (our arithmetic), and it was the highest share of the cap of the seven. The final amendment for each offer was filed 57 to 71 days after expiry in the three most recent cases, so the September 16, 2026 result should appear around November 12 to 26, 2026 (our arithmetic from past filing lags).

There is already a hint. The Offer to Purchase's $2,036,779,880 at $15.21 a share implies about 133.9 million shares on September 1, 2026, and the proxy counts 129,566,413.878 on October 16. The gap of about 4.3 million shares, around $65 million at that price, is consistent with a large repurchase on September 30, net of any new subscriptions (our inference; the fund has not reported the result). For the year to March 31, 2026 the annual report shows 11,095,349 shares repurchased, 9.0% of the 123,741,744 outstanding at the start of the year, and $153,182,464 of cash paid for repurchases, against $173,936,400 of subscriptions. New money has covered redemptions so far.

Does voting “no” affect the tender?

Nothing in the Offer to Purchase refers to the meeting, the proposals or a proxy; the words do not appear in it. The vote and the tender run on separate tracks (our reading). A holder who tenders everything before December 16 still owns the shares until December 31, according to the Offer, so a record-date holder can still vote on December 9 (our reading; confirm with BBR). The one link is indirect: the new AllianceBernstein agreement and a possible change of status take effect around the same time the tender is priced.

Cost and performance in the record

The fund pays BBR a unitary fee of 0.80% a year of net asset value, out of which BBR pays most operating costs, and pays the subadvisers separately, at a weighted average of 0.45% of the assets they manage in the year to March 31, 2026. Advisory fees accrued were $14,753,023 and subadvisory fees $8,215,178. The net expense ratio of 1.27% excludes the costs of the Investment Fund (HWC) the fund owns, so it understates what the money costs end to end.

For the year to March 31, 2026 the adviser's letter says the fund's total return of 9.71% “underperformed the blend of reference indexes” by 13.78%, against 25.59% for the Russell 2000, 23.45% for the Russell 2500 and 25.57% for MSCI ACWI ex-US. It blames a quality bias in a rally led by lower-quality, cyclical stocks and the replacement of a non-US growth manager. It also says one value-biased subadviser returned about 40%. The fund distributed $135,679,065 in that year ($1.05 a share, mostly realized gains), while net assets grew from $1.65 billion to $1.84 billion.

Tendering is a taxable sale for most holders. See Form 8949 and Schedule D for fund sales and, if you hold similar funds, the wash sale rule for tender offers. For another tender fund with a December 31 valuation and a holdback, see Dynamic Alternatives Fund, and for the quarter's other deadlines, the Q4 2026 redemption and tender calendar. Another fund managed by an AB affiliate faces the same merger vote: AB Private Credit Investors Corporation.

What a reader can do with this

• Vote before 11:59 p.m. Eastern on December 8, 2026, by internet, telephone or the card; the proxy points to www.proxyvote.com. An unmarked signed card is voted FOR both proposals, so mark it if you disagree with either.
• Read the definitive proxy when it is filed. The version filed October 23 is preliminary and still has a bracketed mailing date.
• Ask BBR at (212) 313-9870 for the current NAV, the result of the September 2026 offer, and whether the Offer to Purchase will be amended in light of the proxy. The Offer says tendering investors can get the most recent NAV from BBR.
• Decide the tender by December 16 at midnight knowing the price is set on December 31, that a full tender holds back about 2.5% until the audit (about May 2027), and that cash for the first note is due by about January 30, 2027 (our arithmetic). Ask your tax adviser which tax year a December 31 valuation with January payment falls in.
• Check how big the position is against the rest of the portfolio. The fund is long-biased equity with a 13.2% private fund sleeve and has trailed its reference blend in the latest year.

A worked example (our arithmetic): a holder with $500,000 of shares tenders all of them and the NAV on December 31, 2026 is the same as the August 31 figure of $15.21. The first note is 97.5%, or $487,500, due by about January 30, 2027, and about $12,500 is paid after the audit, expected in May 2027. A holder who tenders $200,000 of a $500,000 position gets one note for $200,000, and keeps $300,000, which is above the $25,000 minimum. Neither figure reflects any change in NAV by December 31.

FAQ

All figures are from SEC filings read on EDGAR on October 23, 2026: BBR ALO Fund's Schedule TO-I of October 2, 2026 and its Offer to Purchase (accession 0001398344-26-017809); the preliminary proxy statements of October 9 and October 23, 2026 (0001104659-26-114979 and 0001104659-26-118431); the 2025 definitive proxy of June 4, 2025 (0001104659-25-056461); the annual report for the year ended March 31, 2026 (Form N-CSR, 0001398344-26-010475) and the semiannual report to September 30, 2025 (0001398344-25-022007); eight earlier Schedule TO-I filings and seven final amendments (SC TO-I/A, accessions 0001398344-25-005552, 0001398344-25-011882, 0001398344-25-018579, 0001398344-25-022346, 0001398344-26-003551, 0001398344-26-009769 and 0001398344-26-014088); Equitable Holdings' Form 8-Ks of March 26, July 30 and September 25, 2026 (0000950142-26-000871, 0000950142-26-002207 and 0001333986-26-000048), Corebridge's Form 8-K of July 30, 2026 (0001140361-26-030260) and the joint proxy statement/prospectus of June 23, 2026 (0001193125-26-279668). Percentages marked as our arithmetic are our calculations; the 68% stake of Equitable in AllianceBernstein appears only in the fund's proxy. The result of the September 2026 offer and the definitive proxy had not been filed. This is analysis of public documents, not investment, legal or tax advice.